## Abstract Olaquindox is a new feed additive.[^14^C]Olaquindox, labelled in different positions, was needed for tracer‐studies of pharmacokinetics, biotransformation and residues in several species of animals. 2‐ [N‐(2‐hydroxethyl)‐carbamoyl] −3‐methyl‐[3‐^14^C] quinoxaline‐1,4‐dioxide ([3‐^14^C]
Preparation of 3,3′-dichlorobenzidine-(phenyl-U-14C) dihydrochloride
✍ Scribed by W. P. Duncan; J. C. Wiley Jr.; W. C. Perry
- Publisher
- John Wiley and Sons
- Year
- 1977
- Tongue
- French
- Weight
- 208 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A novel five‐step synthesis of 3,3′‐ dichlorobenzidine‐(phenyl‐U^14^C) dihydrochloride is described. The method consists of the preparation of benzidine‐(phenyl‐U‐^14^C) followed by acetylation, chlorination with N‐chlorosuccinimide (NCS), and hydrolysis. The specific activity of the product was 31.2 mCi/mmole and the overall radiochemical yield was 20% [based on nitrobenzene‐(phenyl‐U‐^14^C)].
📜 SIMILAR VOLUMES
## Abstract Methyl cinnamate ‐3‐^14^C is reduced smoothly in excellent yield to cinnamyl alcohol ‐3‐^14^C by aluminum hydride. without attack of the double bond. After purification by column chromatography cinnamyl alcohol ‐3‐^14^C is obtained with a radioactive overall yield of 65% based on cinnam
14C-Labelled 6-hydroxy-5,7-dimethyl-2-(methylamino)-4-(3-pyridylmethyl)benzothiazole dihydrochloride (14C-E3040 dihydrochloride), required for a study of the phrmacokinetic profile of E3040, a novel dual inhibitor of 5-lipoxygenase and thromboxane A2 synthetase, was synthesized in one step using [2-
thienyl-3-14C]Temocillin has been prepared from [ l-14C]chloroacetic acid via 3-[ 3-I4C] thienylmalonic acid.
I n o r d e r t o s t u d y some a s p e c t s of t h e c e n t r a l metabolism of h i s t a m i n e r 3 3 w e have prepared N -[ H]methylhistamine d i h y d r o c h l o r i d e from [ Hlmethyl i o d i d e by chemical s y n t h e s i s and NT-methyl [a,8,2,4,5-14C51histamine d i h y d r o c h l o r
## Abstract A E. Coli K 12 mutant having lost 2‐keto‐3‐desoxy‐gluconate kinase activity is unable to utilize glucuronate as a unique carbon source. However, this strain is able to partially convert glucuronate into KDG in resting cells conditions reported here. A method is described making it poss